FDA Warning Letter — East Capital Exxon

Case 572645 — FEI 3015114338

The FDA took a Warning Letter action against East Capital Exxon on Jan 24, 2019 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
East Capital Exxon
Date
Jan 24, 2019
Fiscal Year
2019
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.